Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2021 February;112(1) > Minerva Medica 2021 February;112(1):114-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

EDITORIAL   Freefree

Minerva Medica 2021 February;112(1):114-7

DOI: 10.23736/S0026-4806.20.06727-0

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Severe asthma at COVID-19 time: what is new on biologic therapies

Filippo PATRUCCO 1, 2 , Elisa VILLA 3, Valentina FOCI 4, Alida BENFANTE 5, Michela BELLOCCHIA 6, Paolo SOLIDORO 6, 7

1 Division of Respiratory Diseases, Department of Medicine, Maggiore della Carità University Hospital, Novara, Italy; 2 Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; 3 Unit of Pneumology, A.S.L. Genova3, Villa Scassi Hospital, Genoa, Italy; 4 Unit U of Pneumology, Department of Medicine, A.S.L. Vercelli, Vercelli, Italy; 5 ProMISE Department, University of Palermo, Palermo, Italy; 6 Unit U of Pneumology, Department of Cardiovascular and Thoracic Medicine, Città della Salute e della Scienza, University of Turin, Turin, Italy; 7 Department of Medical Sciences, University of Turin, Turin, Italy



top of page